Paradigm Capital Management »

Halozyme Therapeutics shares owned by Paradigm Capital Management

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Paradigm Capital Management from 13F filings

Historical chart of Paradigm Capital Management investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Paradigm Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Paradigm Capital Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $58k 10k 5.80
2012-12-31 $67k 10k 6.70
2012-09-30 $75k 10k 7.50
2012-06-30 $89k 10k 8.90
2012-03-31 $128k 10k 12.80
2011-12-31 $95k 10k 9.50
2011-09-30 $61k 10k 6.10
2011-06-30 $69k 10k 6.90
2011-03-31 $67k 10k 6.70
2010-12-31 $79k 10k 7.90